Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human Papillomavirus-Directed Therapeutics for Human Papillomavirus-Associated Oropharyngeal Cancer. | Cancer J | 2022 | 36165730 | PubTator, text mining | PubMed |
| Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients. | Clin Endocrinol (Oxf) | 2022 | 36161330 | PubTator, text mining | PubMed |
| Nanogels as target drug delivery systems in cancer therapy: A review of the last decade. | Front Pharmacol | 2022 | 36160424 | PubTator, text mining | PubMed |
| Bacterial outer membrane vesicles as a candidate tumor vaccine platform. | Front Immunol | 2022 | 36159867 | PubTator, text mining | PubMed |
| A synthetic DNA template for fast manufacturing of versatile single epitope mRNA. | Mol Ther Nucleic Acids | 2022 | 36159589 | PubTator, text mining | PubMed |
| Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations. | Biomedicines | 2022 | 36140243 | PubTator, text mining | PubMed |
| The Features of Checkpoint Receptor-Ligand Interaction in Cancer and the Therapeutic Effectiveness of Their Inhibition. | Biomedicines | 2022 | 36140182 | PubTator, text mining | PubMed |
| Immunotherapy resistance in esophageal cancer: Possible mechanisms and clinical implications. | Front Immunol | 2022 | 36119033 | PubTator, text mining | PubMed |
| Immunotherapy in head and neck squamous cell carcinoma: a narrative review. | Front Oral Maxillofac Med | 2022 | 36105623 | PubTator, text mining | PubMed |
| Sphingolipid metabolism is associated with osteosarcoma metastasis and prognosis: Evidence from interaction analysis. | Front Endocrinol (Lausanne) | 2022 | 36105405 | PubTator, text mining | PubMed |
| Current landscape and perspective of oncolytic viruses and their combination therapies. | Transl Oncol | 2022 | 36095879 | PubTator, text mining | PubMed |
| The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy. | Front Endocrinol (Lausanne) | 2022 | 36093115 | PubTator, text mining | PubMed |
| Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma. | Front Cell Dev Biol | 2022 | 36092724 | PubTator, text mining | PubMed |
| Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen. | Nat Commun | 2022 | 36088370 | PubTator, text mining | PubMed |
| Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma. | Front Immunol | 2022 | 36072600 | PubTator, text mining | PubMed |
| Ulcerated Cutaneous Melanoma: A Review of the Clinical, Histologic, and Molecular Features Associated with a Clinically Aggressive Histologic Phenotype. | Clin Cosmet Investig Dermatol | 2022 | 36065342 | PubTator, text mining | PubMed |
| An Overview of DNA Methylation Indicators for the Course of Oral Precancer. | Appl Bionics Biomech | 2022 | 36060560 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer. | Front Oncol | 2022 | 36059606 | PubTator, text mining | PubMed |
| Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy. | Sci Transl Med | 2022 | 36044599 | PubTator, text mining | PubMed |
| Distinctive gene expression patterns in pregnancy-associated breast cancer. | Front Genet | 2022 | 36035177 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=23